Shopping Cart 0
Cart Subtotal
USD 0

Denali Therapeutics Inc (DNLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Denali Therapeutics Inc (Denali Therapeutics) is a clinical-stage biopharmaceutical company that focuses on the development of therapeutics for the treatment of neurodegenerative diseases. The company's proprietary drug delivery platform technologies include antibody transport vehicle and enzyme transport vehicle designed to deliver large molecules across the blood-brain barrier (BBB). Its pipeline products are intended for the treatment of Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, lysosomal storage disorder MPS II, neurodegeneration, amyotrophic lateral sclerosis and other indications. The company has development and commercialization rights to all of its programs, including the programs partnered with Takeda. Denali Therapeutics is headquartered in South San Francisco, California, the US.

Denali Therapeutics Inc (DNLI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Denali Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Denali Therapeutics Raises USD130 Million in Series B Financing 12

Denali Therapeutics Raises USD217 Million in Venture Financing 13

Denali Therapeutics Raises USD217 Million in Venture Financing 15

Partnerships 16

Centogene and Denali Therapeutics Enter into Agreement 16

AbCellera Biologics Enters into Agreement with Denali Therapeutics 17

Parkinson's Institute and Denali Therapeutics Enter into Agreement 18

Lonza Enters into Agreement with Denali Therapeutics 19

Takeda Pharma and Denali Therapeutics to Enter into Agreement 20

Denali Therapeutics Enters into Research Agreement with Blaze Bioscience 21

Denali Therapeutics Enters into Research Agreement with ALS Therapy Development Institute 22

Licensing Agreements 23

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 23

Denali Therapeutics Expands Licensing And Collaboration Agreement with F-star 24

Denali Therapeutics Enters Into Licensing Agreement With Genentech 26

Equity Offering 27

Denali Therapeutics Raises USD287.5 Million in IPO 27

Denali Therapeutics Raises USD30 Million in Private Placement of Shares 29

Denali Therapeutics Raises USD7.6 Million in Private Placement of Shares 30

Denali Therapeutics Raises USD88.7 Million in Private Placement of Shares 31

Denali Therapeutics Raises USD122.3 Million in Private Placement of Shares 32

Denali Therapeutics Raises USD35 Million in Private Placement of Shares 33

Denali Therapeutics Raises USD47 Million in Private Placement of Shares 34

Denali Therapeutics Raises USD9.7 Million in Private Placement of Shares 35

Denali Therapeutics Raises USD0.1 Million in Private Placement of Shares 36

Denali Therapeutics Raises USD39.1 Million in Private Placement of Shares 37

Acquisition 38

Denali Therapeutics to Acquire F-star Gamma 38

Denali Therapeutics Acquires Incro Pharma 39

Denali Therapeutics Inc-Key Competitors 40

Denali Therapeutics Inc-Key Employees 41

Denali Therapeutics Inc-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Recent Developments 43

Financial Announcements 43

Aug 09, 2018: Denali Therapeutics reports second quarter 2018 financial results 43

May 11, 2018: Denali Therapeutics Reports First Quarter 2018 Financial Results 44

Mar 19, 2018: Denali Therapeutics Announces Fourth Quarter And Full Year 2017 Financial Results 45

Corporate Communications 46

Aug 07, 2018: Denali Therapeutics Appoints Dana Andersen, Ph.D., as Chief Technical and Manufacturing Officer 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Denali Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Denali Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Denali Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Denali Therapeutics Raises USD130 Million in Series B Financing 12

Denali Therapeutics Raises USD217 Million in Venture Financing 13

Denali Therapeutics Raises USD217 Million in Venture Financing 15

Centogene and Denali Therapeutics Enter into Agreement 16

AbCellera Biologics Enters into Agreement with Denali Therapeutics 17

Parkinson's Institute and Denali Therapeutics Enter into Agreement 18

Lonza Enters into Agreement with Denali Therapeutics 19

Takeda Pharma and Denali Therapeutics to Enter into Agreement 20

Denali Therapeutics Enters into Research Agreement with Blaze Bioscience 21

Denali Therapeutics Enters into Research Agreement with ALS Therapy Development Institute 22

Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 23

Denali Therapeutics Expands Licensing And Collaboration Agreement with F-star 24

Denali Therapeutics Enters Into Licensing Agreement With Genentech 26

Denali Therapeutics Raises USD287.5 Million in IPO 27

Denali Therapeutics Raises USD30 Million in Private Placement of Shares 29

Denali Therapeutics Raises USD7.6 Million in Private Placement of Shares 30

Denali Therapeutics Raises USD88.7 Million in Private Placement of Shares 31

Denali Therapeutics Raises USD122.3 Million in Private Placement of Shares 32

Denali Therapeutics Raises USD35 Million in Private Placement of Shares 33

Denali Therapeutics Raises USD47 Million in Private Placement of Shares 34

Denali Therapeutics Raises USD9.7 Million in Private Placement of Shares 35

Denali Therapeutics Raises USD0.1 Million in Private Placement of Shares 36

Denali Therapeutics Raises USD39.1 Million in Private Placement of Shares 37

Denali Therapeutics to Acquire F-star Gamma 38

Denali Therapeutics Acquires Incro Pharma 39

Denali Therapeutics Inc, Key Competitors 40

Denali Therapeutics Inc, Key Employees 41

Denali Therapeutics Inc, Subsidiaries 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Denali Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.